Clinical trial
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe…
NCT00485225 · Durect, Industry · Completed
Key facts
| NCT number | NCT00485225 |
|---|---|
| Title | Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain |
| Official title | An Open-Label, Two-Stage, Phase II Study to Explore the Titration Schedule for Transitioning Opioid-Experienced Patients With Non-Malignant Moderate to Severe Chronic Pain From Current Opioid Therapy to EN3270. |
| Lead sponsor | Durect, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic, Non Malignant Pain |
| Intervention type | Drug |
| Interventions | EN3270 |
| Enrollment | 77 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 12, 2007 |
| Last update posted | Feb 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: